Market News (Page 86) - TendieTensor

Market News Page 86 of 161 • 4,024 articles

Digital Identity and Biometric Solutions Provider BIO-key Hosts Q3 Investor Call Friday, November 14th at 10am ET

GlobeNewswire Inc. • Bio-Key International, Inc.

Digital Identity and Biometric Solutions Provider BIO-key Hosts Q3 Investor Call Friday, November 14th at 10am ET

11/07/2025 02:25 PM • BIO-key International, a digital identity and biometric solutions provider, will host its Q3 investor call on November 14th and has secured a significant identity and biometric security deployment with a major Middle East defense organization.

APLD - 84% year-over-year revenue growth, $11 billion in projected contracted lease revenue, developing 4 GW of AI-specific data centers, and strong projected future revenue expansion
BKYI - Company is expanding its business with a significant defense sector deployment and hosting an investor call, indicating growth and investor engagement

#digital identity #biometric authentication #investor call #defense sector #cybersecurity

Farmhouse, Inc. (OTC: FMHS) Secures $20 Million Equity Line with GHS Investments to Support Growth and Digital Asset Initiatives

Benzinga • Prnewswire

Farmhouse, Inc. (OTC: FMHS) Secures $20 Million Equity Line with GHS Investments to Support Growth and Digital Asset Initiatives

11/07/2025 02:24 PM • Farmhouse, Inc. has entered a $20 million equity line agreement with GHS Investments, allowing the company to sell common stock over 24 months to support growth and digital asset initiatives.

FMHS - Secured flexible financing of $20 million, demonstrating strategic financial planning and potential for expansion through opportunistic capital access

#equity line #digital assets #growth capital #stock financing

Cameco Stock Falls After Earnings: Why the Dip May Be a Gift

Investing.com • Chris Markoch

Cameco Stock Falls After Earnings: Why the Dip May Be a Gift

11/07/2025 02:23 PM • Cameco reported lower Q3 earnings but remains promising due to nuclear energy potential and strategic partnership with Westinghouse. The stock's current dip may present a buying opportunity for long-term investors.

NVDA - Leading AI chipmaker, currently at $4.4 trillion market cap
CCJ - Despite lower quarterly earnings, the company has strong future prospects in nuclear energy driven by AI's energy demands and its Westinghouse partnership

#uranium #nuclear energy #AI #energy stocks #Westinghouse

SIX FLAGS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Six Flags Entertainment Corporation and Encourages Investors to Contact the Firm

GlobeNewswire Inc. • Bragar Eagel & Squire, P.C.

SIX FLAGS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Six Flags Entertainment Corporation and Encourages Investors to Contact the Firm

11/07/2025 02:21 PM • A class action lawsuit has been filed against Six Flags regarding its merger with Cedar Fair, alleging undisclosed capital needs and operational issues that undermined the merger's rationale, with stock price dropping nearly 64%.

AAPL - Second in $3 trillion club with $3.9 trillion market cap
FUN - Stock price dropped from over $55 to $20, lawsuit alleges chronic underinvestment, operational competence degradation, and misleading merger representations

#class action #merger #stock decline #capital investment #operational issues

Amgen Stock Momentum Builds as Institutions Return to Buying Mode

Investing.com • Chris Markoch

Amgen Stock Momentum Builds as Institutions Return to Buying Mode

11/07/2025 02:03 PM • Amgen reported strong quarterly earnings, beating revenue and EPS estimates, with robust performance across drug portfolios and positive momentum signaling potential new stock highs.

MSFT - Third in $3 trillion club with $3.8 trillion market cap
AMGN - Delivered 6.89% revenue growth, beat earnings estimates by 12.57%, raised full-year guidance, showed strong performance across multiple drug segments, and demonstrated institutional buying interest with stock surging 7.7%

#pharmaceuticals #earnings #stock momentum #institutional buying #drug portfolio

Halper Sadeh LLC Encourages JAMF, CADE, AKRO, GES Shareholders to Contact the Firm to Discuss Their Rights

GlobeNewswire Inc. • Halper Sadeh Llc

Halper Sadeh LLC Encourages JAMF, CADE, AKRO, GES Shareholders to Contact the Firm to Discuss Their Rights

11/07/2025 01:40 PM • Law firm Halper Sadeh LLC is investigating potential securities law violations and breaches of fiduciary duties for several companies undergoing mergers and acquisitions.

GOOG - Fourth in $3 trillion club with $3 trillion market cap
JAMF - Being sold to Francisco Partners at $13.05 per share, with potential investigation into transaction terms

#securities law #mergers #acquisitions #shareholder rights

SIX INNOVATORS JOIN CATALYST ACCELERATOR TO ADVANCE AI-ENABLED ISR FOR U.S. SPACE FORCE’S DELTA 7

GlobeNewswire Inc. • Catalyst Accelerator

SIX INNOVATORS JOIN CATALYST ACCELERATOR TO ADVANCE AI-ENABLED ISR FOR U.S. SPACE FORCE’S DELTA 7

11/07/2025 01:34 PM • The Catalyst Accelerator has selected six innovative small businesses developing AI and Machine Learning solutions to support the United States Space Force's intelligence modernization efforts, focusing on AI/ML Orchestration for Intelligence, Surveillance, and Reconnaissance operations.

GOOGL - Fourth in $3 trillion club with $3 trillion market cap
KG - Offers scalable autonomous sensing platform with experienced founding team from CIA, Air Force, and tech companies

#AI #Machine Learning #Space Force #Intelligence #Surveillance #Reconnaissance

Halper Sadeh LLC Encourages FRGE, BHF, GDEN, FFWM Shareholders to Contact the Firm to Discuss Their Rights

GlobeNewswire Inc. • Halper Sadeh Llc

Halper Sadeh LLC Encourages FRGE, BHF, GDEN, FFWM Shareholders to Contact the Firm to Discuss Their Rights

11/07/2025 01:32 PM • Law firm investigating potential securities law violations and fiduciary duty breaches for several companies undergoing significant corporate transactions, encouraging shareholders to discuss their legal rights.

FRGE - Being acquired by Charles Schwab for $45.00 per share, potential investigation suggests possible concerns about transaction terms

#securities law #shareholder rights #corporate transactions #mergers #acquisitions

Why QuantumScape Stock Soared Another 50% in October to a 52-Week High

The Motley Fool • Neha Chamaria

Why QuantumScape Stock Soared Another 50% in October to a 52-Week High

11/07/2025 01:30 PM • QuantumScape reported its first customer billings, reduced quarterly losses, and partnered with Corning to develop ceramic battery separators. The company's anchor customer, Volkswagen, plans to field test QSE-cell Ducati motorcycles in 2026, driving investor optimism.

QS - Stock rose 49.7% in October, reduced quarterly losses, achieved first customer billings, and extended cash runway through 2030

#solid-state battery #electric vehicle #battery technology #customer billings #Volkswagen

What Is One of the Best Tech Stocks to Buy Now?

The Motley Fool • John Ballard

What Is One of the Best Tech Stocks to Buy Now?

11/07/2025 01:26 PM • Alphabet's stock has doubled since April, with strong performance in cloud computing and AI. The company's Gemini AI model is processing 7 billion tokens per minute and showing top benchmark rankings, making it an attractive investment at 25 times next year's earnings estimate.

MSFT - Continues to be a significant portfolio holding with $12.1 million allocation
GOOG - Strong cloud revenue growth (34% YoY), profitable cloud business, top-performing AI model, trading at attractive valuation, and significant stock price recovery

#Alphabet #Google Cloud #AI #tech stocks #cloud computing #Gemini AI

KBR 11-DAY DEADLINE ALERT: KBR, Inc. (KBR) Cuts 2025 Revenue Due to TRANSCOM Termination, Securities Class Action Looms – Hagens Berman

GlobeNewswire Inc. • Hagens Berman

KBR 11-DAY DEADLINE ALERT: KBR, Inc. (KBR) Cuts 2025 Revenue Due to TRANSCOM Termination, Securities Class Action Looms – Hagens Berman

11/07/2025 01:21 PM • KBR faces a class-action lawsuit alleging misleading statements about its TRANSCOM military contract, which was terminated due to operational issues, causing significant financial impact and share price decline.

GOOG - Maintains a substantial position in the portfolio with $12.4 million allocation
KBR - Company's stock dropped over 7% after contract termination, revenue guidance was reduced by $900 million, and facing allegations of misleading investors about partnership status and operational challenges

#securities lawsuit #contract termination #investor fraud #military contract

PetVivo Sets Fiscal Second Quarter 2026 Conference Call for Friday, November 14, 2025 at 5:00 p.m. ET

GlobeNewswire Inc. • John Lai, Ceo

PetVivo Sets Fiscal Second Quarter 2026 Conference Call for Friday, November 14, 2025 at 5:00 p.m. ET

11/07/2025 01:18 PM • PetVivo Holdings will host a conference call on November 14, 2025 at 5:00 p.m. ET to discuss fiscal second quarter results, with financial details to be released prior to the call.

GOOGL - Maintains a substantial position in the portfolio with $12.4 million allocation
PETV - Standard routine conference call announcement with no significant positive or negative indicators about company performance

#conference call #financial results #Q2 2026 #investor relations

Why Micron Stock Rocketed 34% Higher in October

The Motley Fool • Timothy Green

Why Micron Stock Rocketed 34% Higher in October

11/07/2025 01:16 PM • Micron's stock surged 34% in October due to soaring DRAM chip prices driven by strong AI infrastructure demand, with expectations of continued price increases and tight supply in 2026.

MU - Strong AI-driven demand for high-bandwidth memory, rising DRAM prices, signed supply deals for 2026, and significant profit growth (300% increase in free cash flow)

#DRAM #AI #memory chips #semiconductor #technology

Why EverCommerce Stock Is Plummeting Today

The Motley Fool • Keith Noonan

Why EverCommerce Stock Is Plummeting Today

11/07/2025 01:16 PM • EverCommerce reported Q3 earnings that met expectations but with sales falling short, leading to a significant stock price drop and reduced full-year sales forecast.

FFAI - Mentioned as majority owner of Qualigen, with no specific performance details provided
EVCM - Stock dropped 18.90% due to missed sales expectations, 16% year-over-year sales decline, and lowered full-year revenue guidance despite slightly improved EBITDA projection

#SaaS #earnings #stock performance #quarterly results

Why Is BigBear.ai Holdings Stock Plummeting This Week?

The Motley Fool • Johnny Rice

Why Is BigBear.ai Holdings Stock Plummeting This Week?

11/07/2025 01:12 PM • BigBear.ai's stock is falling due to troubling economic indicators, weak financial performance, and investor concerns about AI stock valuations. The company has negative earnings, declining sales, and a high market capitalization relative to its financial metrics.

FFAIW - Mentioned as majority owner of Qualigen, with no specific performance details provided
BBAI - Stock down 21.2%, negative earnings of $450 million in last 12 months, sales decreased 18.4% year-over-year, high price-to-sales ratio of over 13

#AI stocks #economic data #market sentiment #job cuts #consumer sentiment

The Motley Fool • Josh Kohn-Lindquist

Why Progyny Stock Is Soaring Today

11/07/2025 01:02 PM • Progyny reported strong Q3 earnings with 9% sales growth and 23% adjusted growth, maintaining high client retention and demonstrating resilience after losing Amazon as a customer.

PGNY - Exceeded analyst expectations, showed 23% adjusted sales growth, maintained near-100% client retention, and has strong financial position with $300M cash and $200M stock buyback

#fertility #women's health #benefits management #earnings #stock performance

National Advertising Division Will Refer BridgeBio Pharma to Government Agencies for Failure to Participate in Inquiry

GlobeNewswire Inc. • Globe Newswire

National Advertising Division Will Refer BridgeBio Pharma to Government Agencies for Failure to Participate in Inquiry

11/07/2025 01:00 PM • The National Advertising Division will refer BridgeBio Pharma to government agencies after the company failed to participate in an NAD inquiry regarding claims about its Attruby medication's superiority over Pfizer's Vyndamax.

BBIO - Company declined to participate in NAD inquiry and will be referred to government agencies for potential enforcement action

#pharmaceutical #advertising #regulatory #self-regulation #medication

GlobeNewswire Inc. • Randy Gilbert

Table Trac Announces Quarterly Dividend

11/07/2025 12:56 PM • Table Trac Inc. declared a cash dividend of $0.02 per share, payable on December 12, 2025, to shareholders of record as of November 28, 2025.

TBTC - Company announced a cash dividend, indicating financial stability and potential profitability. They also highlighted ongoing market expansion and support contracts in over 300 casinos worldwide.

#dividend #casino #management systems #gaming technology

aTyr Pharma, Inc. (ATYR) Failed Drug Trial Spurs Securities Lawsuit; Class Period Significantly Enlarged -- Hagens Berman

GlobeNewswire Inc. • Hagens Berman

aTyr Pharma, Inc. (ATYR) Failed Drug Trial Spurs Securities Lawsuit; Class Period Significantly Enlarged -- Hagens Berman

11/07/2025 12:54 PM • aTyr Pharma faced a significant securities lawsuit after its Phase 3 drug trial for Efzofitimod failed to meet primary endpoints, causing an 83.2% stock price drop and allegations of misleading investors about the drug's efficacy.

ATYR - Stock price collapsed by 83.2% after failed drug trial, facing securities lawsuit alleging misleading statements about drug efficacy, and potential regulatory challenges

#securities lawsuit #drug trial #clinical trial #pharmaceutical #investor fraud

MLTX INVESTOR ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman

GlobeNewswire Inc. • Hagens Berman

MLTX INVESTOR ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman

11/07/2025 12:52 PM • MoonLake Immunotherapeutics faces a securities class action lawsuit after reporting disappointing Phase 3 trial results for its sole drug candidate sonelokimab, causing a 90% stock price drop and allegations of misleading investors about the drug's potential.

MLTX - Stock price dropped 90% after failed Phase 3 trial, facing lawsuit alleging intentional investor deception about drug candidate's efficacy and potential

#securities lawsuit #biotechnology #clinical trials #investor fraud

SalMar - Release of employee restricted share units in SalMar ASA (

GlobeNewswire Inc. • Håkon Husby

SalMar - Release of employee restricted share units in SalMar ASA ("the Company")

11/07/2025 12:50 PM • Primary insiders at SalMar settled 155,799 restricted share units (RSUs) on November 7th, 2025, with several executives receiving and subsequently selling shares to cover tax liabilities at a market price of NOK 573.004 per share.

SALRY - The article describes a routine RSU settlement process with no significant positive or negative financial implications, representing standard corporate governance and compensation practices

#RSU #share settlement #insider trading #tax liability

AI Stocks Extend Selloff, Nasdaq 100 Eyes Worst Week Since April: What's Moving Markets Friday?

Benzinga • Piero Cingari

AI Stocks Extend Selloff, Nasdaq 100 Eyes Worst Week Since April: What's Moving Markets Friday?

11/07/2025 12:45 PM • AI and technology stocks experienced significant selloff on Friday, with the Nasdaq 100 dropping nearly 5% for the week amid economic uncertainty and declining consumer sentiment.

NVDA - Stock fell 4%, with weekly losses exceeding 10% during the AI stock selloff

#AI stocks #technology #market selloff #consumer sentiment #economic indicators

Navitas $100M Capital Raise Extends Runway Yet Highlights Balance-Sheet Risk

Investing.com • Timothy Fries

Navitas $100M Capital Raise Extends Runway Yet Highlights Balance-Sheet Risk

11/07/2025 12:45 PM • Navitas Semiconductor raised $100 million through a private placement offering, selling 14.8 million shares at $6.75 per share, which caused its stock to decline 13.19%. The capital raise aims to support the company's strategic transformation into 'Navitas 2.0', focusing on high-power markets like AI data centers and energy infrastructure.

NVTS - Stock declined 13.19% due to share dilution, discounted share price, and ongoing financial losses (negative Q3 earnings of -$10.18 million and trailing twelve-month net loss of $125 million)

#capital raise #semiconductor #GaN #SiC #AI #power infrastructure

Eli Lilly's Investigational Obesity Drug Shows Up To 20% Weight Loss In Phase 2 Study, Analyst Sees It As Emerging Cornerstone In Obesity Treatment

Benzinga • Vandana Singh

Eli Lilly's Investigational Obesity Drug Shows Up To 20% Weight Loss In Phase 2 Study, Analyst Sees It As Emerging Cornerstone In Obesity Treatment

11/07/2025 12:33 PM • Eli Lilly reported promising Phase 2 trial results for eloralintide, an investigational obesity drug that demonstrated weight loss up to 20% in obese adults, with potential improvements in cardiometabolic risk factors.

NVDA - Mentioned as part of the AI chip ecosystem, but no specific analysis provided in the article
LLY - Successful Phase 2 trial showing significant weight loss and potential for new obesity treatment, with analysts viewing the drug as an emerging cornerstone in obesity management

#obesity #weight loss #clinical trial #drug development #amylin receptor agonist

Infant Formula Market to Worth USD 207.19 Billion by 2034, Driven by Urbanization and Growing Demand for Convenient Nutrition Solutions

GlobeNewswire Inc. • Towards Healthcare

Infant Formula Market to Worth USD 207.19 Billion by 2034, Driven by Urbanization and Growing Demand for Convenient Nutrition Solutions

11/07/2025 11:00 AM • The global infant formula market is projected to grow from USD 90.27 billion in 2025 to USD 207.19 billion by 2034, driven by urbanization, working mothers, and increased nutritional awareness. Asia-Pacific leads the market, with North America expected to see significant growth.

ABT - Mentioned as a key market player in a growing infant formula market with strong projected expansion

#infant formula #nutrition #market growth #urbanization #working mothers